IL158433A0 - Toluene sulfonamide-containing anti-tumor composition and method of use thereof - Google Patents

Toluene sulfonamide-containing anti-tumor composition and method of use thereof

Info

Publication number
IL158433A0
IL158433A0 IL15843302A IL15843302A IL158433A0 IL 158433 A0 IL158433 A0 IL 158433A0 IL 15843302 A IL15843302 A IL 15843302A IL 15843302 A IL15843302 A IL 15843302A IL 158433 A0 IL158433 A0 IL 158433A0
Authority
IL
Israel
Prior art keywords
toluene sulfonamide
containing anti
compositions
tumor composition
tumor
Prior art date
Application number
IL15843302A
Other languages
English (en)
Inventor
Rocky S H Shih
John Wu
Original Assignee
Pts Internat Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pts Internat Inc filed Critical Pts Internat Inc
Publication of IL158433A0 publication Critical patent/IL158433A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Botany (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL15843302A 2001-04-16 2002-04-16 Toluene sulfonamide-containing anti-tumor composition and method of use thereof IL158433A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/835,908 US6727287B2 (en) 2001-04-16 2001-04-16 Toluene sulfonamide-containing anti-tumor composition and method of use thereof
PCT/US2002/011786 WO2002083117A1 (en) 2001-04-16 2002-04-16 Toluene sulfonamide-containing anti-tumor composition and method of use thereof

Publications (1)

Publication Number Publication Date
IL158433A0 true IL158433A0 (en) 2004-05-12

Family

ID=25270767

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15843302A IL158433A0 (en) 2001-04-16 2002-04-16 Toluene sulfonamide-containing anti-tumor composition and method of use thereof
IL158433A IL158433A (en) 2001-04-16 2003-10-15 Toluene sulfonamide-containing anti-tumor composition and method of use thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL158433A IL158433A (en) 2001-04-16 2003-10-15 Toluene sulfonamide-containing anti-tumor composition and method of use thereof

Country Status (17)

Country Link
US (1) US6727287B2 (xx)
EP (1) EP1389101B1 (xx)
JP (1) JP2004526760A (xx)
CN (1) CN100471491C (xx)
AT (1) ATE415960T1 (xx)
AU (1) AU2002303350B2 (xx)
BR (1) BR0208961A (xx)
CA (1) CA2444842A1 (xx)
DE (1) DE60230133D1 (xx)
EA (1) EA007685B1 (xx)
ES (1) ES2316565T3 (xx)
HK (1) HK1067545A1 (xx)
IL (2) IL158433A0 (xx)
MX (1) MXPA03009483A (xx)
NZ (1) NZ529513A (xx)
WO (1) WO2002083117A1 (xx)
ZA (1) ZA200308814B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102005005397B4 (de) * 2005-02-05 2008-08-21 Lts Lohmann Therapie-Systeme Ag Isolierung von N-Butylbenzolsulfonamid, Synthese von Benzolsulfonamid-Derivaten sowie Verwendung von N-Butylbenzolsulfonamid und Benzolsulfonamid-Derivaten zur Behandlung der benignen Prostatahyperplasie und/oder des Prostatakarzinoms
US7790928B1 (en) * 2005-04-25 2010-09-07 Albert Raymond Hechinger Therapeutic dimethyl sulfoxide (aka DMSO) compositions and methods of use
WO2007076875A2 (en) * 2006-01-06 2007-07-12 Aarhus Universitet Compounds acting on the serotonin transporter
CN104473914B (zh) * 2015-01-06 2017-01-11 天津红日药业股份有限公司 一种磺酰胺类药物组合物
US10465742B2 (en) 2015-10-29 2019-11-05 Inteva Products, Llc Cable end fitting and cable abutment and method of securement
US9782370B2 (en) * 2015-12-21 2017-10-10 Gongwin Biopharm Holdings Co., Ltd. Pharmaceutical compositions of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma
US9668990B1 (en) * 2016-06-10 2017-06-06 Gongwin Biopharm Holdings Co., Ltd. Benzenesulfonamides compositions for treatment of malignant pleural effusions
US10182998B2 (en) * 2016-06-10 2019-01-22 Gongwin Biopharm Holdings Co., Ltd. Benzenesulfonamide compositions for treatment of malignant pleural effusions
US20180055796A1 (en) * 2016-08-23 2018-03-01 Gongwin Biopharm Holdings Co., Ltd. Pharmaceutical composition exhibiting anti-tumor activity, method for treating patient suffering from cancer and method for inhibiting tumor growth
CN112055586A (zh) * 2017-12-29 2020-12-08 共信医药科技股份有限公司 苯磺酰胺衍生物及调节脂膜筏的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3340148A (en) 1961-03-22 1967-09-05 Gillette Inhibitor Co Treatment of fungus diseases of the skin
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4160452A (en) 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4265874A (en) 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4777049A (en) 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4663308A (en) 1984-07-18 1987-05-05 Medical College Of Ohio Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract
US4764381A (en) 1985-12-06 1988-08-16 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1, 3-hexanediol
US4983396A (en) 1985-12-06 1991-01-08 Key Pharmaceuticals, Inc. Percutaneous penetration enhancer of oleic acid and 2-ethyl-1,3-hexanediol
US5891454A (en) 1997-03-28 1999-04-06 Alexander Wu Anti-cancer drug and special tumor necrotizing agent
CN1073415C (zh) 1997-07-03 2001-10-24 吴宜庄 磺酰胺类化合物在制备抗癌药物中的应用

Also Published As

Publication number Publication date
CN1511032A (zh) 2004-07-07
EP1389101B1 (en) 2008-12-03
IL158433A (en) 2010-11-30
MXPA03009483A (es) 2004-12-06
ES2316565T3 (es) 2009-04-16
DE60230133D1 (de) 2009-01-15
BR0208961A (pt) 2005-02-01
WO2002083117A1 (en) 2002-10-24
CN100471491C (zh) 2009-03-25
CA2444842A1 (en) 2002-10-24
US20030022843A1 (en) 2003-01-30
ZA200308814B (en) 2004-11-23
US6727287B2 (en) 2004-04-27
EP1389101A1 (en) 2004-02-18
JP2004526760A (ja) 2004-09-02
EP1389101A4 (en) 2005-05-04
HK1067545A1 (en) 2005-04-15
EA200301126A1 (ru) 2004-06-24
ATE415960T1 (de) 2008-12-15
EA007685B1 (ru) 2006-12-29
AU2002303350B2 (en) 2007-08-02
NZ529513A (en) 2005-10-28

Similar Documents

Publication Publication Date Title
WO2003016282A3 (en) Substituted 1h-dihydropyrazoles, their preparation and use
MXPA01007451A (es) Porfirinas sustituidas.
AP9901478A0 (en) Compounds for the treatment of ischemia.
ATE238307T1 (de) Substituierte porphyrinen
IL140710A0 (en) Pulmonary delivery of active agents
ID26984A (id) Senyawa-senyawa sulfonamida sebagai antagonis reseptor angiotensin endotelin ganda
MXPA02012817A (es) Drogas antineoplasicas liposomales y uso de las mismas.
MY129189A (en) Prostaglandin agonists and their use to treat bone disorders
AU9102198A (en) Indole-3-carbinol, diindolylmethane and substituted analogs as antiestrogens
DE69928655D1 (de) Substituierte porphyrine
CA2337991A1 (en) Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
UA66865C2 (uk) Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти)
HK1052940A1 (en) Synthetic methods for aplidine and new antitumoralderivatives, methods of making and using them
DE60021381D1 (de) Chinonverbindungen zur behandlung von krankheiten
WO2000018439A3 (de) Verwendung von neoangiogenese-markern für diagnose und therapie von tumoren
YU13301A (sh) Muskarinski agonisti i antagonisti
HK1067545A1 (en) Toluene sulfonamide-containing anti-tumor composition and method of use thereof
DK1056704T3 (da) Antitumormidler
SE9802937D0 (sv) Novel compounds
AU2002350623A1 (en) Targeted thrombosis by tissue factor polypeptides
WO2002041831A3 (en) Inositol derivatives for increasing chloride secretion and inhibiting inflammation
AU2001233912A1 (en) Diagnosis of breast cancer using bcmp-81 as marker
ATE476987T1 (de) Zusammensetzungen und methoden zur behandlung von candidosen
MXPA03010737A (es) Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion.
EP1436279B8 (en) Chemical compounds